These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 22490522

  • 1. HDGF-related protein-3 is required for anchorage-independent survival and chemoresistance in hepatocellular carcinomas.
    Xiao Q, Qu K, Wang C, Kong Y, Liu C, Jiang D, Saiyin H, Jia F, Ni C, Chen T, Zhang Y, Zhang P, Qin W, Sun Q, Wang H, Yi Q, Liu J, Huang H, Yu L.
    Gut; 2013 Mar; 62(3):440-51. PubMed ID: 22490522
    [Abstract] [Full Text] [Related]

  • 2. HRP-3 protects the hepatoma cells from glucose deprivation-induced apoptosis.
    Cai H, Jiang D, Qi F, Xu J, Yu L, Xiao Q.
    Int J Clin Exp Pathol; 2015 Mar; 8(11):14383-91. PubMed ID: 26823754
    [Abstract] [Full Text] [Related]

  • 3. Hepatoma-derived growth factor promotes growth and metastasis of hepatocellular carcinoma cells.
    Yang GY, Zhang AQ, Wang J, Li CH, Wang XQ, Pan K, Zhou C, Dong JH.
    Cell Biochem Funct; 2016 Jun; 34(4):274-85. PubMed ID: 27273265
    [Abstract] [Full Text] [Related]

  • 4. HDGF-related protein-2 (HRP-2) acts as an oncogene to promote cell growth in hepatocellular carcinoma.
    Gao K, Xu C, Jin X, Wumaier R, Ma J, Peng J, Wang Y, Tang Y, Yu L, Zhang P.
    Biochem Biophys Res Commun; 2015 Mar 20; 458(4):849-55. PubMed ID: 25689719
    [Abstract] [Full Text] [Related]

  • 5. Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.
    Chen SC, Hu TH, Huang CC, Kung ML, Chu TH, Yi LN, Huang ST, Chan HH, Chuang JH, Liu LF, Wu HC, Wu DC, Chang MC, Tai MH.
    Oncotarget; 2015 Jun 30; 6(18):16253-70. PubMed ID: 25938538
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MicroRNA-294 Promotes Cell Proliferation, Migration and Invasion in SMMC-7721 Hepatoma Carcinoma Cells by Activating the JNK/ERK Signaling Pathway.
    Cheng X, Chen M, Liu Z.
    Am J Med Sci; 2020 Jun 30; 359(6):365-371. PubMed ID: 32498943
    [Abstract] [Full Text] [Related]

  • 15. ASPP2 suppresses stem cell-like characteristics and chemoresistance by inhibiting the Src/FAK/Snail axis in hepatocellular carcinoma.
    Xu L, Tong X, Zhang S, Yin F, Li X, Wei H, Li C, Guo Y, Zhao J.
    Tumour Biol; 2016 Oct 30; 37(10):13669-13677. PubMed ID: 27473084
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.